Emily E.  Volk, MD, MBA, FCAP

Emily E. Volk, MD, MBA, FCAP

College of American Pathologists (CAP)

President-elect of the College of American Pathologists, Senior VP of Clinical Services, University Health System and Assistant Professor of Pathology and Laboratory Medicine, University of Texas Health, Long School of Medicine, San Antonio

Expertise: PathologySurgical PathologyGastrointestinalCytopathology

Emily E. Volk, MD, MBA, FCAP is the Senior Vice President, Clinical Services for University Health System in San Antonio, Texas. In addition, as a Clinical Assistant Professor of Pathology at the University of Texas-Health, she practices cytopathology and surgical pathology. Dr. Volk, board-certified in anatomic and clinical pathology with subspecialty certification in cytopathology, received her medical degree from the University of Missouri-Kansas City in 1993. Dr. Volk completed her pathology residency training with a certification year in Surgical Pathology with an emphasis in Gastrointestinal Pathology at the Cleveland Clinic Foundation in Cleveland, Ohio in 1998. Dr. Volk completed her fellowship in cytopathology at William Beaumont Hospital, Royal Oak, MI. Dr. Volk serves on the Executive Board of the Texas Society of Pathologists and is past president of the Michigan Society of Pathologists. At the College of American Pathologists, she serves on the Board of Governors and is the Vice-Chair of the Council and Government Professional Affairs. She chairs the Pathologists Quality Registry Committee for the CAP.

No Research/Citations

No Pitches / Articles Found

“As the tests have become more locally available and the turnaround time has become better, the limitations on the previous testing such as travel history and a very limited set of symptoms has been changed.”

- Testing, Testing, and More Testing: Newswise Live COVID-19 Expert Panel

“We know among CAP-accredited laboratories there are more labs doing PCR testing than there are antibody testing. We also know that laboratories are still struggling to get enough reagents and enough supplies and so we do look to public and private partners to clear up those supply chain issues.”

- Testing, Testing, and More Testing: Newswise Live COVID-19 Expert Panel

Available for logged-in users onlyLogin HereorRegister
close
0.07214